Cargando…
Pitavastatin Reduces Inflammation in Atherosclerotic Plaques in Apolipoprotein E-Deficient Mice with Late Stage Renal Disease
OBJECTIVES: Chronic renal disease (CRD) accelerates atherosclerosis and cardiovascular calcification. Statins reduce low-density lipoprotein-cholesterol levels in patients with CRD, however, the benefits of statins on cardiovascular disease in CRD remain unclear. This study has determined the effect...
Autores principales: | Shibasaki, Manabu, Wang, Jian-Guo, Figueiredo, Jose-Luiz, New, Sophie E. P., Quillard, Thibaut, Goettsch, Claudia, Koga, Jun-ichiro, Sonoki, Hiroyuki, Matsumoto, Jiro, Aikawa, Masanori, Aikawa, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569429/ https://www.ncbi.nlm.nih.gov/pubmed/26367531 http://dx.doi.org/10.1371/journal.pone.0138047 |
Ejemplares similares
-
Genesis and growth of extracellular vesicle-derived microcalcification in atherosclerotic plaques
por: Hutcheson, Joshua D., et al.
Publicado: (2016) -
Statins suppress apolipoprotein CIII-induced vascular endothelial cell activation and monocyte adhesion
por: Zheng, Chunyu, et al.
Publicado: (2013) -
Small entities with large impact: microcalcifications and atherosclerotic plaque vulnerability
por: Hutcheson, Joshua D., et al.
Publicado: (2014) -
Effects of nanoparticle-mediated delivery of pitavastatin on atherosclerotic plaques in ApoE-knockout mice and THP-1-derived macrophages
por: Sun, Yujiao, et al.
Publicado: (2020) -
Dynamic Macrophages: Understanding Mechanisms of Activation as Guide to Therapy for Atherosclerotic Vascular Disease
por: Decano, Julius L., et al.
Publicado: (2018)